Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

Cited by (870)

Items 601–700 of 870

1. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders
   Khasan Ibragimov, Gregory Keane, Cristina Carreño Glaría, Jie Jun Cheng, Augusto Eduardo Llosa · 2024 · Cochrane Database of Systematic Reviews
2. Transitional discharge interventions for people with schizophrenia
   Pablo Rosón Rodríguez, Xiao Chen, Marcelo Arancibia M, Luis Garegnani, Camila Micaela Escobar Liquitay, Husam Aldeen Mohammad, Juan Víctor Ariel Franco · 2024 · Cochrane Database of Systematic Reviews
3. Quetiapine versus placebo for schizophrenia
   Sudheer T. Lankappa, Rahul Gandhi · 2012 · Cochrane Database of Systematic Reviews
4. Illness management and recovery programme for people with severe mental illness
   Lisa Korsbek, Helle Stentoft Dalum, Jane Lindschou, Lene Falgaard Eplov · 2014 · Cochrane Database of Systematic Reviews
5. Peer support for schizophrenia
   Wai Tong Chien, Steve Lui, Andrew Clifton · 2013 · Cochrane Database of Systematic Reviews
6. Animal-assisted therapy for people with serious mental illness
   Martin Downes, Rachel Sarah Dean, Fiona J Bath-Hextall · 2013 · Cochrane Database of Systematic Reviews
7. Tai chi for schizophrenia
   Yan Liu, Bo Li, Trentham Furness, Jun Xia, Corey WJ Joseph, Xudong Tang, Jingchen Zheng, Zhenfu Wang · 2015 · Cochrane Database of Systematic Reviews
8. Neurosurgical Epidemiology and Outcomes Assessment
   Hugh J. L. Garton, Frederick George Barker, Stephen J. Haines · 2011 · Elsevier eBooks
9. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
   Michael W Huang, Roger Carl Gibson, Paul J. Moberg, Stanley N. Caroff · 2018 · Cochrane Database of Systematic Reviews
10. Olanzapine dose for people with schizophrenia
    Youssef Latifeh, Mays Mohsen, Sara Mohamad, Tarek Nassif · 2019 · Cochrane Database of Systematic Reviews
11. Psychosocial treatments for relapse prevention in schizophrenia: study protocol for a systematic review and network meta-analysis of randomised evidence
    Irene Bighelli, Alessandro Rodolico, Gabi Pitschel‐Walz, Wulf‐Peter Hansen, Corrado Barbui, Toshi A. Furukawa, Georgia Salanti, Stefan Leucht · 2020 · BMJ Open
12. Flexible Endoscopic Evaluation of Swallowing: A Proposed Checklist
    Ryan J. Burdick, Justine Dallal York, Yael Shapira‐Galitz · 2024 · American Journal of Speech-Language Pathology
13. Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome
    Morteza Zare, Azam Bazrafshan, Reza Malekpour Afshar, Seyed Mohammad Mazloomi · 2018 · Cochrane Database of Systematic Reviews
14. Schizophrenia trials: past, present and future
    Clive Elliott Adams · 2002 · Epidemiologia e Psichiatria Sociale
15. Hypnosis for schizophrenia
    Angelica Izquierdo de Santiago, M Khan · 2004 · Cochrane Database of Systematic Reviews
16. Management of sexual dysfunction due to antipsychotic drug therapy
    M. Berner, M Hagen · 2002 · Cochrane Database of Systematic Reviews
17. Droperidol for acute psychosis
    S. Cure, Simone Carpenter · 2001 · Cochrane Database of Systematic Reviews
18. General physical health advice for people with serious mental illness
    Graeme E Tosh, Andrew Clifton, Shereen Mala, Mick Bachner · 2010 · Cochrane Database of Systematic Reviews
19. Chlorpromazine versus penfluridol for schizophrenia
    Navid Khalili, Mostafa Vahedian, Naemeh Nikvarz, Mojtaba Piri · 2015 · Cochrane Database of Systematic Reviews
20. Horticultural therapy for schizophrenia
    Roberts, Samantha, Bradley, Andrew J · 2011 · Cochrane Database of Systematic Reviews
21. Development, validation and psychometric evaluation of the Chinese version of the biopsychosocial impact scale in orofacial pain patients
    Ze-Yue Ou-Yang, Yao Feng, Dong-Dong Xie, Yifan Yang, Yun Chen, Ning-Xin Chen, Xiao-Lin Su, Bi-Fen Kuang, Jie Zhao, Ya‐Qiong Zhao et al. · 2023 · Frontiers in Psychology
22. Pemphigus scoring systems and their validation studies – A review of the literature
    Darby Boucher, Anna Wilson, Dédée F. Murrell · 2023 · Dermatologica Sinica
23. Behavioural interventions for reducing weight gain in schizophrenia
    Guy Faulkner, Markus J. Duncan, Margaret Hahn, Gary J. Remington, Tony A. Cohn · 2013 · Cochrane Database of Systematic Reviews
24. Institutional Conflicts of Interest: Protecting Human Subjects, Scientific Integrity, and Institutional Accountability
    G. Duval · 2004 · Journal of Law, Medicine & Ethics
25. Haloperidol versus risperidone for schizophrenia
    Sujoy Ray, Amita Ray, Arun Gopi, Robert Hunter · 2017 · Cochrane Database of Systematic Reviews
26. Risperidone (oral forms) for people with schizophrenia
    Tarek Turk, Mahmoud Alkhatib, Ghadir Abbas, Mhd Khaled Jawish, Omar Mohammad Hammamieh Alshar, Hamza Abou Alchamat, Adib Essali · 2017 · Cochrane Database of Systematic Reviews
27. Clozapine versus risperidone for people with schizophrenia
    Claudia Asenjo Lobos, Marcela Cortés-Jofré, Carolina Fonseca, Stefan Leucht, Eva Madrid A, Xavier Bonfill · 2018 · Cochrane Database of Systematic Reviews
28. The specific methodological features of scientific research in the field of balneotherapy
    Персиянова-Дуброва Анна Леонидовна, Бадалов Назим Гаджиевич, D V Kavunenko · 2019 · Problems of Balneology Physiotherapy and Exercise Therapy
29. Clozapine (generic versus branded) for people with schizophrenia
    Khaled Turkmani, Mohamad Essam Marwa, Basel Ahmad, Tareq Ahmad, Ali Alrstom, Adib Essali · 2019 · Cochrane Database of Systematic Reviews
30. Haloperidol versus olanzapine for people with schizophrenia
    Khasan Ibragimov, Gregory Keane, Cristina Carreño Glaría, Jie Cheng, Augusto Eduardo Llosa · 2019 · Cochrane Database of Systematic Reviews
31. Reporting of patient-reported outcomes in trials on alcohol use disorder: a meta-epidemiological study
    Alexander Douglas, Elizabeth Payton Garrett, Jordan Staggs, Cole Williams, Samuel Shepard, Audrey Wise, Cody Hillman, Ryan Ottwell, Micah L. Hartwell, Matt B. Vassar · 2022 · BMJ Evidence-Based Medicine
32. Aripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychoses
    Jayanti Bhattacharjee, Hany George G El-Sayeh · 2016 · Cochrane Database of Systematic Reviews
33. Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
    Myrto T. Samara, Bartosz Helfer, Philipp Rothe, Stefan Leucht · 2015 · Cochrane Database of Systematic Reviews
34. Meta-cognitive training for schizophrenia
    Giuseppe Guaiana, Valeria Lucarini, Ikenna D. Ebuenyi, Massimiliano Abbatecola, Federica Tarantino, Alessandra Santoro, Gianluca Ghiandi, Arianna Cappiello, Antonio Pinto · 2023 · Cochrane Database of Systematic Reviews
35. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
    Irene Bighelli, Myrto T. Samara, Alessandro Rodolico, Wulf‐Peter Hansen, Stefan Leucht · 2021 · Cochrane Database of Systematic Reviews
36. Anticholinergics versus placebo for neuroleptic-induced parkinsonism
    Rebecca Dickenson, Stefan Momčilović, Lorna Donnelly · 2014 · Cochrane Database of Systematic Reviews
37. Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia
    Stefan Leucht · 2006 · International Clinical Psychopharmacology
38. Development, validity and reliability of a postal questionnaire assessing health states relevant to young persons with stroke in Sweden
    Susanne Margareta Palmcrantz, Lotta Widén Holmqvist, Disa Kathryn Sommerfeld · 2010 · Disability and Rehabilitation
39. Risk assessment for aggressive behaviour in schizophrenia
    Maritta Anneli Valimaki, Tella Lantta, Heli M Hätönen, Raija Kontio, Shuying Zhang · 2016 · Cochrane Database of Systematic Reviews
40. Olanzapine versus placebo for people with schizophrenia
    Yan Li, Changjun Du, Ni Jiaxiang, Yang Liqiang, Fang Qi · 2019 · Cochrane Database of Systematic Reviews
41. Selective noradrenaline reuptake inhibitors for schizophrenia
    Paul Matthews, Jamie Horder · 2012 · Cochrane Database of Systematic Reviews
42. Repetitive transcranial magnetic stimulation (rTMS) for panic disorder
    Zeping Xiao, Chunbo Li, Jijun Wang · 2011 · Cochrane Database of Systematic Reviews
43. Sertindole versus other atypical antipsychotics for schizophrenia
    Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Sandra Schwarz, Franziska Schmidt, Ruth A. Lewis, Werner Kissling, Stefan Leucht · 2007 · Cochrane Database of Systematic Reviews
44. Ziprasidone versus other atypical antipsychotics for schizophrenia
    Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmidt, Sandra Schwarz, Paranthaman Sethupathi Bhoopathi, Stefan Leucht · 2007 · Cochrane Database of Systematic Reviews
45. Chlorpromazine versus metiapine for schizophrenia
    Morteza Zare, Azam Bazrafshan, Maryam Okhovati, Shahrzad Mazhari, Ruzbe Mousavi · 2015 · Cochrane Database of Systematic Reviews
46. Cognitive behaviour therapy versus psychosocial treatments for schizophrenia
    Chris Jones, David Hacker, Irene Cormac, Alan Meaden, Claire B Irving · 2010 · Cochrane Database of Systematic Reviews
47. Asenapine versus placebo for schizophrenia
    Alistair Hay, Amy Byers, Marco Sereno, Manpreet Kaur Basra, Snigdha Dutta, Iram Jalil · 2015 · Cochrane Database of Systematic Reviews
48. Antipsychotic combinations for schizophrenia
    Christoph Ulrich Correll, Werner Kissling, Christine Rummel‐Kluge, Stefan Leucht · 2003
49. Virtual reality for treatment compliance for people with serious mental illness
    Maritta Anneli Valimaki, Heli M Hätönen, Mari Lahti, Marjo Kurki, Anja Hottinen, Kiki Metsäranta, Tanja Riihimäki, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews
50. Amisulpride versus other atypical antipsychotics for schizophrenia
    Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmidt, Sandra Schwarz, Joaquim I Silveira da Mota Neto, Werner Kissling, Stefan Leucht · 2007 · Cochrane Database of Systematic Reviews
51. Sex differences in the efficacy and tolerability of antipsychotic drugs in people with an acute exacerbation of schizophrenia: protocol for an individual-participant-data, dose-response, network meta-analysis
    Spyridon Siafis, Yuki Furukawa, Johannes Schneider‐Thoma, Nobuyuki Nomura, Natalia E. Fares‐Otero, Bram W C Storosum, Jasper Brian Zantvoord, Christian J. Schwarz, Julia Schulz, Horst Naiser et al. · 2025 · F1000Research
52. Celecoxib for schizophrenia
    Shahin Akhondzadeh, Amirhossein Modabbernia, Shervin Taslimi, Ali Daneshmand, Mohammadreza Ostovaneh · 2011 · Cochrane Database of Systematic Reviews
53. Asenapine versus other atypical antipsychotics for schizophrenia
    Adrian Preda, Lawrence R. Faziola · 2010 · Cochrane Database of Systematic Reviews
54. Olanzapine depot for schizophrenia
    Isuru Herath Mudiyanselage, Jagannathan Alagarsamy, Sandhya Kachhap, Mahesh Jayaram · 2009 · Cochrane Database of Systematic Reviews
55. Antipsychotic treatment and adherence in schizophrenia
    Christoph Ulrich Correll, Chris Abbott, Samuel J. Keith, Peter Michael Haddad · 2016 · Oxford University Press eBooks
56. Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses
    Jayanti Bhattacharjee, Hany George G El-Sayeh · 2016 · Cochrane Database of Systematic Reviews
57. Ausschluss der Arthroskopie bei Gonarthrose aus dem GKV-Leistungskatolog: Beruht diese Entscheidung auf wissenschaftlichen Kriterien?
    Thoralf Randolph Liebs, Steffen Berger · 2017 · Zeitschrift für Orthopädie und Unfallchirurgie
58. Humour-based interventions for people with schizophrenia
    Yasushi Tsujimoto, Yuri Nakamura, Masahiro Banno, Kunihiro Kohmura, Hiraku Tsujimoto, Yuki Kataoka · 2021 · Cochrane Database of Systematic Reviews
59. Pourquoi ne peut-on pas faire confiance à la plupart des résultats issus de la recherche ?
    John P. A. Ioannidis · 2021 · L Évolution Psychiatrique
60. Increasing antipsychotic dose for non response in schizophrenia
    Bartosz Helfer, Stefan Leucht, Philipp Rothe, Myrto T. Samara · 2015 · Cochrane Database of Systematic Reviews
61. Risk assessment for aggressive behaviour in schizophrenia
    Maritta Anneli Valimaki, Tella Lantta, Raija Kontio · 2024 · Cochrane Database of Systematic Reviews
62. Cariprazine versus placebo for schizophrenia
    Norah Essali, Ibrahem Hanafi, Adib Essali · 2016 · Cochrane Database of Systematic Reviews
63. The evaluation of reporting of patient-reported outcomes in MDD: A meta-epidemiological study of clinical trials
    Kirstien Minley, Caleb Smith, Kelsi Batioja, Andriana Mercedes Peña, Samuel Shepard, Benjamin Heigle, Micah Daniel Kee, Audrey Wise, Cody Hillman, Ryan Ottwell et al. · 2022 · Journal of Psychiatric Research
64. Zuclopenthixol versus placebo for schizophrenia
    Michael Lacey, Mahesh Jayaram · 2015 · Cochrane Database of Systematic Reviews
65. Omega-3 fatty acids for bipolar disorder (Review)
    Paul Montgomery, Richardson Aj · 2009
66. Pharmacological interventions for acute and transient psychotic disorder (ATPD)
    Saeed Farooq, Muhammad Rehman, Farooq Naeem · 2015 · Cochrane Database of Systematic Reviews
67. Anticholinergic discontinuation for antipsychotic-induced extra-pyramidal symptoms
    Simi R Pereira, Albert Michael · 2017 · Cochrane Database of Systematic Reviews
68. Brexpiprazole versus placebo for people with schizophrenia
    Azam Bazrafshan, Morteza Zare, Maliheh Sadat Bazrafshani, Fatemeh Zare, Shahrzad Mazhari · 2017 · Cochrane Database of Systematic Reviews
69. Parenting interventions for people with schizophrenia or related serious mental illness
    Jessica Radley, Claire Grant, Jane Barlow, Louise Johns · 2020 · Cochrane Database of Systematic Reviews
70. Acetylsalicylic acid (aspirin) for schizophrenia
    Tracey Roberts, Farhad Shokraneh, Selin Nur · 2016 · Cochrane Database of Systematic Reviews
71. Fluphenazine decanoate (timing of administration) for people with schizophrenia
    Fatima Abbas, Tawfik Mamoun Rajab, Omar Alsamarrai, Nawras Alhalabi, Sarah Zaher Addeen, Oubadah Mheish, Aisha Aljojo, Adib Essali · 2017 · Cochrane Database of Systematic Reviews
72. Antipsychotic medication for those with both schizophrenia and learning disability
    Lorna Duggan, Jane Brylewski · 2001
73. Yoga for schizophrenia
    Abigail Knowles, Jonathan Chadwick, Davy Vancampfort · 2013 · Cochrane Database of Systematic Reviews
74. Chlorpromazine versus clotiapine for schizophrenia
    Shahrzad Mazhari, Ali S. Goughari, Saeed Esmailian, Armita Shahesmaeili · 2015 · Cochrane Database of Systematic Reviews
75. Open general medical wards versus specialist psychiatric units for acute psychoses
    FW Hickling, W Abel, Paul Garner · 2003 · Cochrane Database of Systematic Reviews
76. Pharmacotherapies for sleep disturbances in Alzheimer's disease
    Amirhossein Modabbernia, Daniel A. Cohen, Shervin Taslimi, Mandana Ashrafi, Jenny M. McCleery · 2011 · Cochrane Database of Systematic Reviews
77. Levomepromazine for schizophrenia
    Parthipan Sivaraman, Aloka Mitra, Mahesh Jayaram · 2009 · Cochrane Database of Systematic Reviews
78. HIV prevention advice for people with serious mental illness
    Nicola Wright, Athfah Akhtar, Graeme E Tosh, Andrew Clifton · 2012 · Cochrane Database of Systematic Reviews
79. Perphenazine for schizophrenia
    Stefan Leucht, Benno Hartung · 2001 · Cochrane Database of Systematic Reviews
80. HIV prevention advice for people with serious mental illness
    Nicola Wright, Athfah Akhtar, Graeme E Tosh, Andrew Clifton · 2014 · Cochrane Database of Systematic Reviews
81. Aripiprazole versus placebo for schizophrenia
    Ravindra B Belgamwar, Hany George G El-Sayeh · 2007 · Cochrane Database of Systematic Reviews
82. Antipsychotic medication for childhood-onset schizophrenia
    Eilis Kennedy, AP Robatto Nunes · 2003 · Cochrane Database of Systematic Reviews
83. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
    James Sampford, Stephanie J Sampson · 2013 · Cochrane Database of Systematic Reviews
84. Bromperidol decanoate (depot) for schizophrenia
    Marianna Purgato, Clive Elliott Adams · 2011 · Cochrane Database of Systematic Reviews
85. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
    Marianna Boso, Andrea Cipriani, Corrado Barbui · 2007 · Cochrane Database of Systematic Reviews
86. Acceptance and Commitment Therapy for schizophrenia and related disorders
    Naeem, Farooq, Asmer, M. Selim, Khoury, Bassam, Kingdon, David, Farooq, Saeed · 2015 · Cochrane Database of Systematic Reviews
87. Asenapine versus typical antipsychotics for schizophrenia
    Ajit Kumar, Manoj Narayan, Haroon Raja, Manoj J Mathen · 2012 · Cochrane Database of Systematic Reviews
88. Collecting subjective and rating scale data within a single case study design: cognitive behavioural therapy for a person experiencing psychosis
    Joanna Carden, A. JONES · 2009 · Journal of Psychiatric and Mental Health Nursing
89. Haloperidol discontinuation for schizophrenia
    Adib Essali, Khaled Turkmani, Shaimaa Aboudamaah, Alaa AbouDamaah, Mohammad Reyad Dia'a Aldeen, Mohamad Essam Marwa, Nawar Almounayer · 2014 · Cochrane Database of Systematic Reviews
90. Replication and contradiction of highly cited research papers: a lesson for the Secretary of State for Health?
    Roxanne C. Keynejad, Clare Holt, Tony Rao · 2015 · BJPsych Bulletin
91. Aripiprazole versus brexpiprazole for people with schizophrenia
    Nora Angélica Martínez-Vélez, Raúl Iván Escamilla-Orozco, Yvonne Flores-Medina, Ricardo Arturo Saracco-Álvarez, Mauricio Rosel-Vales, Ismael Aguilar Salas, Graciela Yazmín Sánchez Hernández · 2023 · Cochrane Database of Systematic Reviews
92. Post-incident debriefing for people with schizophrenia after coercive measures
    Maritta Anneli Valimaki, Jaakko Varpula, Tella Lantta · 2025 · Cochrane Database of Systematic Reviews
93. Cognitive remediation therapy plus standard care versus standard care for people with schizophrenia
    Alexandra Pentaraki, Bello Utoblo, Eleni Maria Kokkoli · 2017 · Cochrane Database of Systematic Reviews · Retracted
94. Celecoxib plus standard care for people with schizophrenia
    Ayesha Kotecha, Rachel Upthegrove · 2018 · Cochrane Database of Systematic Reviews
95. Ensayos clínicos aleatorizados
    A. Cobos · 2010 · Elsevier eBooks
96. Nidotherapy for people with schizophrenia
    Ian J Chamberlain, Stephanie J Sampson · 2013 · Cochrane Database of Systematic Reviews
97. Transitional discharge techniques for people with serious mental illness
    Emtithal Rezk, Husam Aldeen Mohammad, Ammar Haikal, Ayman Albakour · 2012 · Cochrane Database of Systematic Reviews
98. Monetary incentives for schizophrenia
    Rosanna Michalczuk, Amy Mitchell · 2009 · Cochrane Database of Systematic Reviews
99. Interventions for psychosis in adolescents
    Steve D Wright, Paul Swamidhas Sudhakar Russell · 2004 · Cochrane Database of Systematic Reviews
100. Olanzapine discontinuation for schizophrenia
     Fares Alahdab, Omar Alhalabi, Ghaith Attwa, Ghaith Mousa Basha, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews